Mainga Hamaluba
48 results
Children's Oxygen Administration Strategies And Nutrition Trial (COAST-Nutrition): a protocol for a phase II randomised controlled trial.Kiguli, S.
Olopot-Olupot, P.
Alaroker, F.
Engoru, C.
Opoka, R. O.
Tagoola, A.
Hamaluba, M.
Mnjalla, H.
Mpoya, A.
Mogaka, C.
Nalwanga, D.
Nabawanuka, E.
Nokes, J.
Nyaigoti, C.
Briend, A.
van Woensel, J. B. M.
Grieve, R.
Sadique, Z.
Williams, T. N.
Thomas, K.
Harrison, D. A.
Rowan, K.
Maitland, K.
Wellcome Open Res, (2021). 6:221
Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya.Orangi, S.
Pinchoff, J.
Mwanga, D.
Abuya, T.
Hamaluba, M.
Warimwe, G.
Austrian, K.
Barasa, E.
Vaccines (Basel), (2021). 9:
Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review.Abouyannis, M.
Aggarwal, D.
Lalloo, D. G.
Casewell, N. R.
Hamaluba, M.
Esmail, H.
PLoS Negl Trop Dis, (2021). 15:e0009589
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.Hamaluba, M.
van der Pluijm, R. W.
Weya, J.
Njuguna, P.
Ngama, M.
Kalume, P.
Mwambingu, G.
Ngetsa, C.
Wambua, J.
Boga, M.
Mturi, N.
Lal, A. A.
Khuroo, A.
Taylor, W. R. J.
Goncalves, S.
Miotto, O.
Dhorda, M.
Mutinda, B.
Mukaka, M.
Waithira, N.
Hoglund, R. M.
Imwong, M.
Tarning, J.
Day, N. P. J.
White, N. J.
Bejon, P.
Dondorp, A. M.
Lancet Infect Dis, (2021). 21:1395-1406
Randomised controlled trial of oxygen therapy and high-flow nasal therapy in African children with pneumonia.Maitland, K.
Kiguli, S.
Olupot-Olupot, P.
Hamaluba, M.
Thomas, K.
Alaroker, F.
Opoka, R. O.
Tagoola, A.
Bandika, V.
Mpoya, A.
Mnjella, H.
Nabawanuka, E.
Okiror, W.
Nakuya, M.
Aromut, D.
Engoru, C.
Oguda, E.
Williams, T. N.
Fraser, J. F.
Harrison, D. A.
Rowan, K.
Coast trial group
Intensive Care Med, (2021). 47:566-576
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.Juan-Giner, A.
Kimathi, D.
Grantz, K. H.
Hamaluba, M.
Kazooba, P.
Njuguna, P.
Fall, G.
Dia, M.
Bob, N. S.
Monath, T. P.
Barrett, A. D.
Hombach, J.
Mulogo, E. M.
Ampeire, I.
Karanja, H. K.
Nyehangane, D.
Mwanga-Amumpaire, J.
Cummings, D. A. T.
Bejon, P.
Warimwe, G. M.
Grais, R. F.
Lancet, (2021). 397:119-127
Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study.Jao, I.
Marsh, V.
Che Chi, P.
Kapulu, M.
Hamaluba, M.
Molyneux, S.
Bejon, P.
Kamuya, D.
Bioethics, (2020). 34:819-832
Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya.Njuguna, P.
Maitland, K.
Nyaguara, A.
Mwanga, D.
Mogeni, P.
Mturi, N.
Mohammed, S.
Mwambingu, G.
Ngetsa, C.
Awuondo, K.
Lowe, B.
Adetifa, I.
Scott, J. A. G.
Williams, T. N.
Atkinson, S.
Osier, F.
Snow, R. W.
Marsh, K.
Tsofa, B.
Peshu, N.
Hamaluba, M.
Berkley, J. A.
Newton, C. R. J.
Fondo, J.
Omar, A.
Bejon, P.
BMC Med, (2019). 17:124